Literature DB >> 19104763

[Therapy-resistant "psoriasis vulgaris"].

W Kempter1, A Stein, A Bauer, G Wozel.   

Abstract

A 61-year-old patient had a 25-year history of erythematous scaling lesions, diagnosed and treated as psoriasis vulgaris. He presented with a growing nodule within the erythematous plaque. Biopsy shows epithelioid cell granulomas with prominent Langhans giant cells. There was no sign of a squamous cell carcinoma. The tuberculin test was strongly positive and M. tuberculosis complex was detected in the biopsy material by PCR. He was diagnosed with lupus vulgaris, the most frequent form of cutaneous tuberculosis. Other types include tuberculosis verrucosa cutis, tuberculosis cutis orificialis and disseminated military tuberculosis. The patient was treated with rifampicin, isoniazid, pyrazinamide and ethambutol for two months, following a four month treatment with rifampicin and isoniazid. The skin lesions rapidly resolved under antituberculotic treatment.

Entities:  

Mesh:

Year:  2009        PMID: 19104763     DOI: 10.1007/s00105-008-1647-3

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  3 in total

1.  Tuberculosis verrucosa cutis presenting as an annular hyperkeratotic plaque.

Authors:  Shahbaz A Janjua; Amor Khachemoune; Sabrina Guillen
Journal:  Cutis       Date:  2006-11

Review 2.  Cutaneous tuberculosis.

Authors:  V N Sehgal
Journal:  Dermatol Clin       Date:  1994-10       Impact factor: 3.478

Review 3.  Cutaneous tuberculosis: diagnosis and treatment.

Authors:  Joseph Barbagallo; Patricia Tager; Rosemary Ingleton; Ranella J Hirsch; Jeffrey M Weinberg
Journal:  Am J Clin Dermatol       Date:  2002       Impact factor: 7.403

  3 in total
  1 in total

1.  Lupus vulgaris masquerading as tumorous growth.

Authors:  Chandra Sekhar Sirka; Arpita Nibedita Rout; Pankaj Kumar; Suvendu Purkait
Journal:  Indian J Dermatol Venereol Leprol       Date:  2021 [SEASON]       Impact factor: 2.545

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.